Corcept Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Corcept Therapeutics, Inc. (CORT)

34.34 -0.39 (-1.12%) USD | NASDAQ | Jan 20, 10:41

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	Upgrade
Johnson & Johnson	Upgrade
United Therapeutics Corp.	--
Ultragenyx Pharmaceutical, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade